The design and conduct of clinical trials to limit missing data
- 25 July 2012
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 31 (28), 3433-3443
- https://doi.org/10.1002/sim.5519
Abstract
This article summarizes recommendations on the design and conduct of clinical trials of a National Research Council study on missing data in clinical trials. Key findings of the study are that (a) substantial missing data is a serious problem that undermines the scientific credibility of causal conclusions from clinical trials; (b) the assumption that analysis methods can compensate for substantial missing data is not justified; hence (c) clinical trial design, including the choice of key causal estimands, the target population, and the length of the study, should include limiting missing data as one of its goals; (d) missing‐data procedures should be discussed explicitly in the clinical trial protocol; (e) clinical trial conduct should take steps to limit the extent of missing data; (f) there is no universal method for handling missing data in the analysis of clinical trials – methods should be justified on the plausibility of the underlying scientific assumptions; and (g) when alternative assumptions are plausible, sensitivity analysis should be conducted to assess robustness of findings to these alternatives. This article focuses on the panel's recommendations on the design and conduct of clinical trials to limit missing data. A companion paper addresses the panel's findings on analysis methods. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Missing Data Handling in Chronic Pain TrialsJournal of Biopharmaceutical Statistics, 2011
- Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendationsPain, 2010
- Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trialThe Lancet, 2010
- Bias reduction with an adjustment for participants' intent to dropout of a randomized controlled clinical trialClinical Trials, 2007
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Undue Inducement: Nonsense on Stilts?American Journal of Bioethics, 2005
- Sample size calculation for complex clinical trials with survival endpointsControlled Clinical Trials, 1995
- Toward more definitive clinical trialsControlled Clinical Trials, 1980
- Inference and missing dataBiometrika, 1976